A case of post-allogeneic transplant pure red cell aplastic anemia successfully treated with ibrutinib
-
-
关键词:
- 纯红细胞再生障碍性贫血 /
- 异基因造血干细胞移植 /
- 伊布替尼 /
- 慢性移植物抗宿主病
-
-
[1] Aung FM,Lichtiger B,Bassett R,et al.Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation[J].Br J Haematol,2013,160(6):798-805.
[2] 中华医学会血液学分会红细胞疾病(贫血)学组.获得性纯红细胞再生障碍诊断与治疗中国专家共识(2020年版)[J].中华血液学杂志,2020,41(3):177-184.
[3] Wada S,Asano-Mori Y,Yamamoto H,et al.No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation[J].Bone Marrow Transplant,2019,54(5):765-768.
[4] Sackett K,Cohn CS,Fahey-Ahrndt K,et al.Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant[J].J Clin Apher,2018,33(1):108-12.
[5] Balasubramanian SK,Sadaps M,Thota S,et al.Rational management approach to pure red cell aplasia[J].Haematologica,2018,103(2):221-230.
[6] Long Z,Yu F,Du Y,et al.Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus[J].Ann Hematol,2018,97(11):2047-2054.
[7] Chen Z,Liu X,Chen M,et al.Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency[J].Ann Hematol,2020,99(4):737-741.
[8] de Claro RA,McGinn KM,Verdun N,et al.FDA Approval:Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia[J].Clin Cancer Res,2015,21(16):3586-3590.
[9] Zhang Q,Chen J,Gao H,et al.Drug repurposing:Ibrutinib exhibits immunosuppressive potential in organ transplantation[J].Int J Med Sci,2018,15(11):1118-1128.
-
计量
- 文章访问数: 362
- PDF下载数: 133
- 施引文献: 0
下载: